NOIDS.wiki
Calculator
Shop Potency Calculator
Cannabis Science

Dronabinol: Pharmaceutical Synthetic THC (Marinol)

Cannabinoid · Pharmaceutical (synthetic THC)

IntoxicatingPharmaceuticalFDA-approvedSynthetic THC

Dronabinol is pharmaceutical Δ-9-THC: the same molecule as the THC in cannabis, but made synthetically and FDA-approved as a medicine (brand names Marinol and Syndros). It is prescribed for chemotherapy-induced nausea and for appetite loss and weight loss in AIDS.

Full name
Dronabinol (synthetic Δ-9-THC)
Molecular formula
C21H30O2
Molar mass
314.46 g/mol
Identifier
CAS 1972-08-3
Status
FDA-approved (Marinol 1985, Syndros 2016)
Intoxicating?
Yes, it is THC

What it is approved for

The same molecule, a controlled dose

Because dronabinol is chemically identical to plant Δ-9-THC, it has the same effects. The advantage of the pharmaceutical is a known, consistent dose in an oil capsule or oral solution. It is approved for nausea and vomiting from chemotherapy that has not responded to usual treatments, and for anorexia with weight loss in AIDS.

FAQ

Is dronabinol the same as THC? Yes. Dronabinol is synthetic Δ-9-THC, the identical molecule to the THC in cannabis, formulated as an approved medicine for a consistent dose.

What is dronabinol used for? Chemotherapy-induced nausea and vomiting, and appetite/weight loss in AIDS.

How is oral dronabinol metabolized in the human body? Oral dronabinol undergoes extensive first-pass hepatic metabolism by CYP2C9 and CYP3A4 enzymes, converting into psychoactive 11-hydroxy-THC (11-OH-THC) before further oxidation into inactive THC-COOH.

Clinical Trials, First-Pass Hepatic Metabolism, and Regulatory Approvals

Dronabinol is pure synthetic (-)-trans-delta-9-tetrahydrocannabinol formulated in sesame oil soft gelatin capsules (Marinol) or oral solution (Syndros). Following oral administration, dronabinol undergoes extensive first-pass hepatic hydroxylation via cytochrome P450 2C9 and 3A4 enzymes to yield the equipotent psychoactive metabolite 11-hydroxy-delta-9-THC (11-OH-THC) and the inactive oxidation product 11-nor-9-carboxy-delta-9-THC (THC-COOH), resulting in systemic bioavailability of 10% to 20% (NIH DailyMed). Its regulatory approvals rest on pivotal randomized clinical trials demonstrating antiemetic efficacy in cancer chemotherapy-induced nausea and vomiting (Sallan et al., 1975, New England Journal of Medicine, PubMed PMID 1099449) and significant appetite stimulation in patients with AIDS-related anorexia and weight loss (Beal et al., 1995, Journal of Pain and Symptom Management, PubMed PMID 7775790).

Sources

  1. Dronabinol (Marinol/Syndros) FDA prescribing information, DailyMed. dailymed.nlm.nih.gov

Part of the NOIDS cannabinoids index. Educational reference, not medical advice.

This article is for educational purposes only. Always follow local laws regarding cannabis preparation and use.

Scroll to Top